Feature

FDA chief calls for stricter scrutiny of electronic health records


 

Food and Drug Administration Commissioner Scott Gottlieb, MD, on March 20, 2019, called for tighter scrutiny of EHR systems, which have prompted thousands of reports of patient injuries and other safety problems over the past decade.

“What we really need is a much more tailored approach, so that we have appropriate oversight of EHRs when they’re doing things that could create risk for patients,” Dr. Gottlieb said in an interview with Kaiser Health News.

Dr. Gottlieb was responding to “Botched Operation,” a report published March 18 by KHN and Fortune magazine. The investigation found that the federal government has spent more than $36 billion over the past 10 years to switch doctors and hospitals from paper to digital records systems. In that time, thousands of reports of deaths, injuries, and near misses linked to EHRs have piled up in databases – including at least one run by the FDA.

Dr. Gottlieb said Congress would need to enact legislation to define when an EHR would require government oversight. He said that the digital records systems, which store a patient’s medical history, don’t fit neatly under the agency’s existing mandate to regulate items such as drugs and medical devices.

Dr. Gottlieb said the best approach might be to say that an EHR that has a certain capability becomes a medical device. He called EHRs a “unique tool,” noting that the risks posed by their use aren’t the same as for a traditional medical device implanted in a patient. “You need a much different regulatory scheme,” he said.

The 21st Century Cures Act of 2016 excludes the FDA from having oversight over EHRs as a medical device.

Pages

Recommended Reading

Scott Gottlieb to step down as FDA commissioner
MDedge Hematology and Oncology
Prior authorization an increasing burden
MDedge Hematology and Oncology
Clinical trials unavailable for more than half of all cancer patients
MDedge Hematology and Oncology
‘Difficult’ discussions reduced anxiety, depression in life-limiting cancer patients
MDedge Hematology and Oncology
Advance care planning codes not being used
MDedge Hematology and Oncology
Match Day 2019: Residency spots increase, but improvements needed
MDedge Hematology and Oncology
Death by a thousand clicks
MDedge Hematology and Oncology
Breast cancer survivors offer realistic strategies for easing cost burden
MDedge Hematology and Oncology
Will patient rewards for lower-cost choices impact physicians?
MDedge Hematology and Oncology
MedPAC puts Part B reference pricing, binding arbitration on the table
MDedge Hematology and Oncology